15 November 2007
Journal of Alzheimer's Disease special issue explores multifaceted aspects of AD: From social to molecular problems
Amsterdam — A recently published special issue of the Journal of Alzheimer's Disease contains the contributions from experts in the field of aging, dementia and Alzheimer’s disease, who attended the “Fourth Annual Meeting on Brain aging and Dementia: From successfu
15 November 2007
Biomarkers for Alzheimer's disease can be trusted in clinical trials
Göteborg, Sweden, 15 November 2007 -- The best-established biomarkers for Alzheimer’s disease have a low natural variation over two years. The results speak for the inclusion of these biomarkers in clinical trials of novel drugs against Alzheimer’s disease.
15 November 2007
Binding of proteases to fibrillar amyloid protein and its inhibition by Congo red are identified
Staten Island, NY—Scientists from the New York State Institute for Basic Research in Developmental Disabilities (IBR) report today in the November issue of the Journal of Alzheimer’s Disease that the proteases neprilysin and insulysin bind to fibrillar amyloid bet
30 September 2007
New Study Finds that Testosterone May Reverse Effects of Alzheimer's Disease
An Edith Cowan University (ECU) study has found that testosterone replacement therapy lowers the levels of the toxic Alzheimer’s disease protein, beta amyloid, in an animal model and in a pilot study in humans.
11 July 2007
Journal of Alzheimer's Disease Achieves Significant Impact Factor
July 11, 2007, Amsterdam, The Netherlands and San Antonio, TX, USA – International publisher IOS Press and the Editorial Board of the Journal of Alzheimer’s Disease (JAD) are proud to announce that the journal has achieved a 3.058 Impact Factor th
23 May 2007
2007 Alzheimer Award to Jing Zhang, M.D., Ph.D.
The 2007 Alzheimer Award is being presented to Jing Zhang, M.D., Ph.D., in recognition of his outstanding work, "Detection of Biomarkers with a Multiplex Quantitative Proteomic Platform in Cerebrospinal Fluid of Patients with Neurodegenerative Disorders," by Fadi
31 January 2007
Detection of Abeta oligomers in cerebrospinal fluid using flow cytometry: The AlzAlertTM assay as a tool for the diagnosis of Alzheimer's disease
Halle (Saale) - The company ACGT ProGenomics AG i.I., Germany, announced the publication of relevant clinical data on its AlzAlertTM assay in CSF in the renowned journal Journal of Alzheimer's Disease. The paper appears in Vol.
21 December 2006
Cardiff discovery has potential for Alzheimer's Disease treatment
An antibody with the potential to block production of the brain chemical linked to Alzheimer’s disease has been developed by Cardiff University researchers.
17 November 2006
The Role of Metals in Alzheimer's Disease Explored
Alzheimer’s disease (AD) is a devastating condition and its causes are still largely unknown. Various metals have been implicated as possible contributors to the development of AD.
Pages
